Sunshine Biopharma, Inc. (SBFM)
1.14
+0.03 (2.70%)
Upcoming Events
Latest Headlines
Health Canada approves Sunshine Biopharma's generic Atenolol tablets
August 31, 2026 9:02 AM - StreetInsider
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
August 31, 2026 9:01 AM - StreetInsider
Form S-1 Sunshine Biopharma Inc.
August 28, 2026 4:16 PM - SEC Filing
Form 8-K Sunshine Biopharma Inc. For: Aug 25
August 28, 2026 4:06 PM - SEC Filing
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026 9:20 AM - StreetInsider
Sunshine Biopharma reports tumor suppression results with K1.1 mRNA program
August 26, 2026 9:02 AM - StreetInsider
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
August 26, 2026 9:01 AM - StreetInsider
Sunshine Biopharma gets Canadian approval for generic Enalapril
August 19, 2026 9:02 AM - StreetInsider
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
August 19, 2026 9:01 AM - StreetInsider
Form SCHEDULE 13G/A Sunshine Biopharma Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
August 14, 2026 4:16 PM - SEC Filing
Form 10-Q Sunshine Biopharma Inc. For: Jun 30
August 13, 2026 4:08 PM - SEC Filing
Form SCHEDULE 13G/A Sunshine Biopharma Inc. Filed by: INTRACOASTAL CAPITAL, LLC
August 13, 2026 10:21 AM - SEC Filing
Form 4 Sunshine Biopharma Inc. For: Aug 07 Filed by: NATAN DAVID
August 11, 2026 4:23 PM - SEC Filing
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
August 7, 2026 9:01 AM - StreetInsider
Sunshine Biopharma gets Canadian approval for generic Dienogest tablets
August 4, 2026 9:02 AM - StreetInsider
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
August 4, 2026 9:01 AM - StreetInsider
Form 8-K Sunshine Biopharma Inc. For: Aug 03
August 3, 2026 8:52 AM - SEC Filing
Health Canada approves Sunshine Biopharma's generic Ondansetron
July 28, 2026 8:04 AM - StreetInsider
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
July 28, 2026 8:01 AM - StreetInsider
Form 424B5 Sunshine Biopharma Inc.
July 20, 2026 4:34 PM - SEC Filing
Sunshine Biopharma sets up $4M at-the-market stock offering
July 20, 2026 4:28 PM - StreetInsider
Form 8-K Sunshine Biopharma Inc. For: Jul 20
July 20, 2026 4:27 PM - SEC Filing
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
July 20, 2026 8:31 AM - StreetInsider
Form 8-K Sunshine Biopharma Inc. For: Jul 08
July 10, 2026 4:54 PM - SEC Filing
Form SCHEDULE 13G Sunshine Biopharma Inc. Filed by: Alta Partners LLC
July 8, 2026 6:06 PM - SEC Filing
Sunshine Biopharma gets Canadian approval for generic Anastrozole
June 25, 2026 8:01 AM - StreetInsider
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
June 25, 2026 8:00 AM - StreetInsider
Form DEF 14C Sunshine Biopharma Inc. For: Jun 08
June 8, 2026 4:05 PM - SEC Filing
Full Article List
